Zeo ScientifiX (ZEOX) Profit After Tax (2012 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Profit After Tax of -$145000.0 for Q2 2026, up 89.58% year-over-year from -$76486.5 in Q2 2025, and up 82.98% quarter-over-quarter from -$852000.0 in Q1 2026.
Zeo ScientifiX (ZEOX) Profit After Tax (2012 - 2026) Analysis & Trends
Zeo ScientifiX's Profit After Tax history runs 15 years deep, the most recent figure standing at -$145000.0 for Q2 2026.
- In Q2 2026, Profit After Tax rose 89.58% year-over-year to -$145000.0; the TTM figure through Apr 2026 stood at -$3.9 million (up 20.73% YoY), while the FY2025 annual figure was -$5.5 million, down 17.34% from the prior year.
- Profit After Tax for Q2 2026 stood at -$145000.0, up from -$852000.0 in the prior quarter.
- The five-year high for Profit After Tax was -$145000.0 in Q2 2026, with the low at -$3.0 million in Q4 2022.
- The 5-year median for Profit After Tax is -$1.4 million (2024), against an average of -$1.5 million.
- The sharpest annual moves came in 2022 and 2026: Profit After Tax plunged 215.12% in 2022, then soared 89.58% in 2026.
- Zeo ScientifiX's Profit After Tax stood at -$3.0 million in 2022, then soared by 63.87% to -$1.1 million in 2023, then dropped by 14.94% to -$1.3 million in 2024, then surged by 35.01% to -$815000.0 in 2025, then surged by 82.21% to -$145000.0 in 2026.
- Business Quant data shows ZEOX's Profit After Tax at -$145000.0 in Q2 2026, -$852000.0 in Q1 2026, and -$815000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | -145,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -145,000.00 |
| Jan 31, 2026 | -852,000.00 |
| Oct 31, 2025 | -815,000.00 |
| Jul 31, 2025 | -2.07 Mn |
| Apr 30, 2025 | -1.39 Mn |
| Jan 31, 2025 | -1.24 Mn |
| Oct 31, 2024 | -1.25 Mn |
| Jul 31, 2024 | -1.01 Mn |
| Apr 30, 2024 | -1.40 Mn |
| Jan 31, 2024 | -1.04 Mn |
| Oct 31, 2023 | -1.09 Mn |
| Jul 31, 2023 | -1.62 Mn |
| Apr 30, 2023 | -1.99 Mn |
| Jan 31, 2023 | -2.29 Mn |
| Oct 31, 2022 | -3.02 Mn |
| Jul 31, 2022 | -2.73 Mn |
| Apr 30, 2022 | -1.46 Mn |
| Jan 31, 2022 | -1.69 Mn |
| Oct 31, 2021 | -958,152.00 |
| Jul 31, 2021 | -1.41 Mn |